RIGEL PHARMACEUTICALS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized
RIGEL PHARMACEUTICALS, INC. (RIGL) reported Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized of 158.12 thousand shares for the 1-month period ending 2024-07-31, per its 10-Q filed 2024-11-07.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized · last filed 2024-11-07
- 2024-07-31: Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized 1 month 158.12K shares.
- 2024-05-31: Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized 1 month 650.00K shares.
- 2024-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized 1 month 78.23K shares; Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized 1 month as first filed 375.00K shares.
- 2023-05-31: Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized 1 month 4.00M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized 1 month | Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized 1 month as first filed |
|---|---|---|
| 2024-07-31 | 158.12K shares 10-Q · filed 2024-11-07 | |
| 2024-05-31 | 650.00K shares 10-Q · filed 2024-11-07 | |
| 2024-03-31 | 78.23K shares 10-Q · filed 2024-08-06 | 375.00K shares 10-Q · filed 2024-05-07 |
| 2023-05-31 | 4.00M shares 10-Q · filed 2023-11-07 | |
| 2023-04-30 | 356.00K shares 10-Q · filed 2023-11-07 | 108.60K shares 10-Q · filed 2023-08-01 |
| 2022-05-31 | 5.00M shares 10-Q · filed 2022-11-03 | |
| 2022-04-30 | 626.00K shares 10-Q · filed 2022-11-03 | |
| 2022-01-31 | 610.00K shares 10-Q · filed 2022-11-03 | |
| 2021-09-30 | 469.00K shares 10-Q · filed 2022-05-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 |